Neftali Eduardo Antonio-Villa

Biography

Clinical Researcher at the National Institute of Cardiology Ignacio Chavez.

Associate Professor at the National Autonomous University of Mexico.

2024 Lown Scholar from Harvard TH Chan School of Public Health

My research interests are focused on gaining a deeper understanding of the mechanisms underlying cardiometabolic diseases. I utilize data mining, machine learning, and artificial intelligence to identify metabolic patterns for personalized medicine.

Education and Training

• MD, Medicine
  National Autonomous University of Mexico
• Ph.D., Medicine
  National Autonomous University of Mexico
• Specialist, Applied Statistics
  National Autonomous University of Mexico

Awards and Honors

• Bernard Lown Scholar, 2024
  Harvard T.C. Chan School of Public Health
• MGH Global Health Community Engagement Award, 2023
  Massachusetts General Hospital
• 73rd Nobel Laureate Fellow, 2023
  Mexican Academy of Science
• Special Mention – 2023 Mexico City Youth Award, 2023
  Mexico City Youth Institute
• Best Scientific Work of the XXVI National Meeting of Researchers of the Ministry of Health, 2022
  Ministry of Health - Mexico
• Social Service Award "Gustavo Baz Prada", 2022
  National Autonomous University of Mexico
• Featured Abstract Award 2021, 2021
  Endocrine Society
• Special Mention Scientific Work of the XXV National Meeting of Researchers of the Ministry of Health, 2021
  Ministry of Health - Mexico
• Presidential Poster Competition (Adipose Tissue, Appetite, and Obesity), 2020
  Endocrine Society
• Early Career Forum Award, 2019
  Endocrine Society

Publications

• Correction: Assessment of psychological terror and its impact on mental health and quality of life in medical residents at a reference medical center in Mexico: A cross-sectional study.

  Estrada VME, Antonio-Villa NE, Bello-Chavolla OY, Cuevas-García CF, Gutiérrez PLV, Noriega ISC, García-Cortés LR. PLoS One 2025

• Prevalence of obesity in people with and without type 1 diabetes across Belgium, Kuwait, and Mexico: an IMI2 SOPHIA study.

  Al Ozairi E, Steenackers N, Pazmino S, Alattar AT, Al Kandari J, Almeda-Valdes P, Antonio-Villa NE, Delfin C, Faradji RN, García-Tuomola A A, Irshad M, Longenecker JC, Rosen J, Hurtado Del Pozo C, Sparsø T, Lavens A, Mathieu C, Van der Schueren B, le Roux CW. EClinicalMedicine 2024

• Smoking, all-cause, and cause-specific mortality in individuals with diabetes in Mexico: an analysis of the Mexico city prospective study.

  Ramírez-García D, Fermín-Martínez CA, Sánchez-Castro P, Núñez-Luna A, Basile-Alvarez MR, Fernández-Chirino L, Vargas-Vázquez A, Díaz-Sánchez JP, Kammar-García A, Almeda-Valdés P, Berumen-Campos J, Kuri-Morales P, Tapia-Conyer R, Alegre-Díaz J, Seiglie JA, Antonio-Villa NE, Bello-Chavolla OY. BMC Public Health 2024 Sep 02

• Disentangling the relationship between biological age and frailty in community-dwelling older Mexican adults.

  Fermín-Martínez CA, Ramírez-García D, Antonio-Villa NE, López-Teros MT, Seiglie JA, Pérez RCC, Peña CG, Gutiérrez-Robledo LM, Bello-Chavolla OY. medRxiv 2024 Aug 20

• Clinical and treatment profiles of arterial hypertension in Mexico during the COVID-19 pandemic: a cross-sectional survey endorsed by the "Collaborative Group on Arterial Hypertension".

  Palomo-Piñón S, Antonio-Villa NE, Rangel-Zertuche RA, Berumen-Lechuga MG, Medina-Serrano JM, García-Cortés LR, Mejia-Rodríguez O, León-Vázquez ML, González-Dzib RDS, González-Coronado VJ, Álvarez-Aguilar C, Paniagua-Sierra JR, Alcocer L. Front Public Health 2025